By Dr. Ari Weitzner An article in Archives demonstrated a much higher rate of progression in visual fields in glaucoma in those patients with an elevated anti-cardiolipin. Many have argued that there is an inflammatory and/or vascular component to glaucoma, and this would buttress that argument. Maybe we should be ordering this test and being a […]
Gene Therapy A Future Possibility In Glaucoma, Clinician Says
With 14 regions of the genome associated with primary open-angle glaucoma known and four genes identified, possible applications for genetics in glaucoma could include an additional therapeutic option, a clinician said here.
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY(TM)
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY(TM) (bromfenac ophthalmic solution) 0.09% as a once-daily prescriptio…
Push And Pull Get Eyes To Work Together
Researchers appear to have found a better way to correct sensory eye dominance, a condition in which an imbalance between the eyes compromises fine depth perception. The key is a push-pull training method in which the weak eye is made to work while vis…
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY
ISTA Pharmaceuticals, Inc. , today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the…
Carl Zeiss Meditec Introduces New Innovations: ‘Creating What’s To Come’ At AAO 2010
AAO Booth #1408 – Carl Zeiss Meditec today unveiled its newest product innovations at the 2010 American Academy of Ophthalmology annual meeting in Chicago. Powered by the FORUM Ophthalmic Data Management System, the new Glaucoma Workplace features FORU…